Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice.

Publication

Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice.

Journal Paper/Review - Sep 6, 2017

Seiffge David Julian, Traenka Christopher, Polymeris Alexandros A, Thilemann Sebastian, Wagner Benjamin, Hert Lisa, Delignette-Muller Marie Laure, Gensicke Henrik, Peters Nils, Nickel Christian H, Stippich Christoph, Sutter Raoul, Marsch Stephan C, Fisch Urs, Guzman Raphael, De Marchis Gian Marco, Lyrer Philippe A, Bonati Leo H, Tsakiris Dimitrios A, Engelter Stefan T

Citation

Seiffge D, Traenka C, Polymeris A, Thilemann S, Wagner B, Hert L, Delignette-Muller M, Gensicke H, Peters N, Nickel C, Stippich C, Sutter R, Marsch S, Fisch U, Guzman R, De Marchis G, Lyrer P, Bonati L, Tsakiris D, Engelter S. Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice. J Stroke 2017; 19:347-355.

Type

Journal Paper/Review (English)

Journal

J Stroke 2017; 19

Publication Date

Sep 6, 2017

Issn Print

2287-6391

Pages

347-355

Brief description/objective

Standard operating procedures (SOP) incorporating plasma levels of rivaroxaban might be helpful in selecting patients with acute ischemic stroke taking rivaroxaban suitable for IVthrombolysis (IVT) or endovascular treatment (EVT).